Merck & Company, Inc. vs Revolution Medicines, Inc. — Stock Comparison

MRK
Merck & Company, Inc.
$112.16
▲ 2.73%
vs
RVMD
Revolution Medicines, Inc.
$139.48
▼ 3.22%
Q·Score Winner
Merck & Company, Inc.
MRK6.7/10vs 5.1/10

Q·Score Breakdown

6.7
Neutral
Overall
5.1
Bearish
6.2
Quality
2
7
Health
7.7
6.2
Growth
3.8
7.2
Valuation
4.7
7.1
Sentiment
9.2
MRK

Forward P/E of 11.5× is low relative to sector peers.

RVMD

100% of 21 covering analysts have a positive rating.

low return on equity (-58%).

Analyst Consensus

BUY
Target $129.74 (+15.7%)
27 analysts
BUY
Target $174.30 (+25.0%)
20 analysts

Fundamentals

MRK
RVMD
31.5×
Trailing P/E
11.5×
Forward P/E
-26.6×
13.6%
Profit Margin
0.0%
76.6%
Gross Margin
0.0%
ROE
-58.1%
4.9%
Revenue Growth
Earnings Growth
0.28
Beta
1.01
Price / Book
$277.0B
Market Cap
$29.7B
$73 – $125
52-Week Range
$34 – $156

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →